Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test

NCT05837663 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05837663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2023
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplantation